Expedition Therapeutics: Funding, Investors & Team (Oct 2026)
Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and respiratory diseases.
Expedition Therapeutics has raised $280M across 2 funding rounds on record, the most recent a Series B of $115M announced in Aug 2026.
That round is above the $8.5M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Expedition Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2026.
Expedition Therapeutics Funding Rounds
Expedition Therapeutics raised $165M in a Series A announced in Oct 2025.
10 months later, a Series B of $115M was announced in Aug 2026.
Expedition Therapeutics Investors
14 investors are recorded in total; the 5 named above are those the record identifies.
Expedition Therapeutics Founders and Leadership Team
Contact details for the Expedition Therapeutics team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Expedition Therapeutics Funding Compared to Other Biotechnology Startups
Expedition Therapeutics' latest round of $115M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Expedition Therapeutics in Biotechnology and San Francisco
Companies Similar to Expedition Therapeutics
Rion Vet mission is to drive the regenerative medicine revolution.
Modulight Bio develops an optogenetic platform intended for the treatment of neurological disorders.
Nomax Therapeutics develops a healthcare technology platform to provide therapies for neurodegenerative…
Gregor Diagnostics is a molecular diagnostics company developing a screening test technology for prostate…
Gut Brain Axis Therapeutics is a biotechnology company that offers treatment for Autism Spectrum Disorder…
iOrganBio is a pioneering cell production platform.
BlueWhale Bio is committed to advancing cell-based therapeutics through manufacturing innovation.
NILO Therapeutics is a biotechnology and therapeutics company.
AccufyDx is a Biotechnology Research firm working to change MRD analysis for early detection.Accufy…
Predicta Biosciences provides molecular diagnostics and immunotherapeutic discovery services for…
Celaid Therapeutics is a biotech company that develops cell therapies for blood cancer, intractable blood…
Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients.
Expedition Therapeutics Funding FAQs
What does Expedition Therapeutics do?
Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and respiratory diseases.
How much funding has Expedition Therapeutics raised?
Expedition Therapeutics has raised $280M across 2 rounds on record. The most recent is a Series B of $115M announced in Aug 2026.
When did Expedition Therapeutics last raise funding?
Expedition Therapeutics' most recent funding round on record is a Series B of $115M, announced in Aug 2026.
Who has invested in Expedition Therapeutics?
Investors on record for Expedition Therapeutics include General Atlantic, RA Capital Management, Balyasny Asset Management, Vivo Capital, Novo Holdings. FundedIQ records 14 investors in total.
Who is the CEO of Expedition Therapeutics?
Yi Larson is listed as CEO at Expedition Therapeutics.
Where is Expedition Therapeutics headquartered?
Expedition Therapeutics is based in San Francisco, United States.
How many employees does Expedition Therapeutics have?
Expedition Therapeutics is in the 1-10 employee band.
When was Expedition Therapeutics founded?
Expedition Therapeutics was founded in 2024.
How does Expedition Therapeutics' funding compare to other Biotechnology startups?
Expedition Therapeutics' latest round of $115M is above the $8.5M median round size for Biotechnology companies on FundedIQ across 27 tracked companies over the last two years.
About FundedIQ's Expedition Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Expedition Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.